Pharma-ecology : (Record no. 79110)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 07930cam a22007938i 4500 |
| 001 - CONTROL NUMBER | |
| control field | on1042077388 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20201009115341.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr |n||||||||| |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 180619s2018 nju ob 001 0 eng |
| 010 ## - LIBRARY OF CONGRESS CONTROL NUMBER | |
| LC control number | 2018029534 |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | DLC |
| Language of cataloging | eng |
| Description conventions | rda |
| Transcribing agency | DLC |
| Modifying agency | OCLCO |
| -- | OCLCF |
| -- | N$T |
| -- | EBLCP |
| -- | UIU |
| -- | DG1 |
| -- | MERER |
| -- | UKMGB |
| -- | OTZ |
| -- | OCLCQ |
| 066 ## - CHARACTER SETS PRESENT | |
| Alternate G0 or G1 character set | (S |
| 015 ## - NATIONAL BIBLIOGRAPHY NUMBER | |
| National bibliography number | GBB8I6276 |
| Source | bnb |
| 016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER | |
| Record control number | 019080867 |
| Source | Uk |
| 019 ## - | |
| -- | 1054128975 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781119312307 |
| Qualifying information | (ePub) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1119312302 |
| Qualifying information | (ePub) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781119312321 |
| Qualifying information | (electronic bk. : oBook) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1119312329 |
| Qualifying information | (electronic bk. : oBook) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 9781119312284 |
| Qualifying information | (hardback) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Canceled/invalid ISBN | 1119312280 |
| Qualifying information | (hardback) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781119312291 |
| Qualifying information | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1119312299 |
| Qualifying information | (electronic bk.) |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | UKMGB |
| System control number | 019080867 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | CHVBK |
| System control number | 549244638 |
| 029 1# - OTHER SYSTEM CONTROL NUMBER (OCLC) | |
| OCLC library identifier | CHNEW |
| System control number | 001025653 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1042077388 |
| Canceled/invalid control number | (OCoLC)1054128975 |
| 037 ## - SOURCE OF ACQUISITION | |
| Stock number | 9781119312307 |
| Source of stock number/acquisition | Wiley |
| 042 ## - AUTHENTICATION CODE | |
| Authentication code | pcc |
| 050 10 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RA1238 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 071000 |
| Source | bisacsh |
| 082 00 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.9/02 |
| Edition number | 23 |
| 084 ## - OTHER CLASSIFICATION NUMBER | |
| Classification number | SCI013040 |
| -- | TEC010010 |
| Number source | bisacsh |
| 049 ## - LOCAL HOLDINGS (OCLC) | |
| Holding library | MAIN |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Jjemba, Patrick K., |
| Relator term | author. |
| 245 10 - TITLE STATEMENT | |
| Title | Pharma-ecology : |
| Remainder of title | the occurrence and fate of pharmaceuticals and personal care products in the environment / |
| Statement of responsibility, etc. | Patrick K. Jjemba. |
| 250 ## - EDITION STATEMENT | |
| Edition statement | Second edition. |
| 263 ## - PROJECTED PUBLICATION DATE | |
| Projected publication date | 1811 |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Place of production, publication, distribution, manufacture | Hoboken, NJ : |
| Name of producer, publisher, distributor, manufacturer | Wiley, |
| Date of production, publication, distribution, manufacture, or copyright notice | [2018] |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource. |
| 336 ## - CONTENT TYPE | |
| Content type term | text |
| Content type code | txt |
| Source | rdacontent |
| 337 ## - MEDIA TYPE | |
| Media type term | computer |
| Media type code | c |
| Source | rdamedia |
| 338 ## - CARRIER TYPE | |
| Carrier type term | online resource |
| Carrier type code | cr |
| Source | rdacarrier |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | "This book links the health and environmental sciences professions; concern over the occurrence and fate of pharmaceutical and personal care products (PPCPs) in the environment. Knowledge about the ecological impact of PPCPs is dynamically changing as better and more sensitive detection techniques become available, and new information has come up since the book first published. This new edition brings the readership up-to-date and continues to bridge the gap between medicine / public health and environmental science. It is an approach that arouses interest in the topic among health-care providers, engineers, toxicologists, pharmacists, ecologists, microbiologists, chemists, and policy makers. Highlights the biological effects of pharmaceutical compounds under clinical settings, their modes of action, approximate quantities consumed Provides researchers and scientists with important background data on the environmental impacts of PPCPs, which is currently gaining much notice Updates information on PPCPs ecological impacts, based on new detection techniques, and adds open-ended questions to each chapter"-- |
| Assigning source | Provided by publisher. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | "Sales handles: - Links the health and environmental sciences professions' concern over the occurrence and fate of pharmaceutical and personal care products (PPCPs) in the environment - Highlights the biological effects of pharmaceutical compounds under clinical settings, their modes of action, approximate quantities consumed - Provides researchers and scientists with important background data on the environmental impacts of PPCPs, which is currently gaining much notice - Updates information on PPCPs' ecological impacts, based on new detection techniques, and adds open-ended questions to each chapter Bridges the gap between medicine / public health and environmental science Market description: Engineers, toxicologists, ecologists, microbiologists, chemists involved in pollution and environmental analysis. Regulatory agencies like the EPA or FDA, which are concerned with the potential negative impacts of pharmaceutical products and waste. Pharmaceutical professionals who design and develop pharmaceutical and personal care products (PPCPs) and who need to understand how they impact the environment"-- |
| Assigning source | Provided by publisher. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE | |
| Bibliography, etc. note | Includes bibliographical references and index. |
| 588 0# - SOURCE OF DESCRIPTION NOTE | |
| Source of description note | Print version record and CIP data provided by publisher; resource not viewed. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Intro; Title Page; Copyright Page; Contents; Preface; Chapter 1 Usage of Pharmaceutical and Personal Care Products; 1.1 Pharmaceutical Consumption Trends; Study Questions; References; Chapter 2 Most Prescribed Pharmaceuticals and Related Endpoints; 2.1 Antihypertensive and Cardiovascular; 2.2 Anxiolytic Sedatives, Hypnotics, and Antipsychotics; 2.3 Analgesics and Anti-inflammatory Drugs; Study Questions; References; Chapter 3 Usage of Antimicrobial Agents and Related Endpoints; 3.1 Cell Wall Synthesis Inhibiting Antibiotics; 3.2 Inhibitors of Protein Synthesis |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 3.3 Nucleic Acid Synthesis Inhibitors3.4 Antagonism to Metabolic Processes; 3.5 Antibiotics that Disrupt Membrane Integrity; 3.6 Other Antimicrobials; Study Questions; References; Chapter 4 Usage of Other Groups of Pharmaceuticals and Related Endpoints; 4.1 Gastrointestinal Drugs; 4.2 Antidiabetic Drugs; 4.3 Diuretics and Electrolytes; 4.4 Thyroid System Medication; 4.5 Respiratory Drugs; 4.6 Oral Contraceptive and Reproductive Therapeutics; 4.7 Biophosphonates and Other Skeletal Ailment Drugs; 4.8 Steroids; 4.9 Hematologic Drugs; 4.10 Nutritional Drugs; 4.11 Triptans; 4.12 Anesthetics |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 4.13 Antineoplastics and ImmunosuppressantsStudy Questions; References; Chapter 5 Personal Care Products of Environmental Concern; 5.1 Fragrances and Musks; 5.2 Ultraviolet Light Filters; 5.3 Detergents; 5.4 Disinfectants; Study Questions; References; Chapter 6 Detection and Occurrence of PPCPs in the Environment; 6.1 Detection of PPCPs in the Environment; 6.1.1 Detection Using Instrumentation; 6.1.2 Detection Using Bioassays; 6.2 Occurrence of PPCPs in Various Environments; 6.2.1 Aquatic Systems; 6.2.1.1 PPCPs in Wastewater; 6.2.1.2 PPCPs in Surface Water; 6.2.1.3 PPCPs in Groundwater |
| 505 8# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | 6.2.1.4 PPCPs in Potable Water6.2.2 Occurrence of PPCPs in Sediments; 6.2.3 Occurrence of PPCPs in Soil; 6.2.4 PPCPs in Aerial Environments; 6.3 Excretion as a Driver of Pharmaceutical Occurrence in the Environment; Study Questions; References; Chapter 7 Ecopharmacokinetics and Ecopharmacodynamics of PPCPs; 7.1 Overview of Pharmacokinetics and Pharmacodynamics; 7.1.1 PPCP Sorption and Bioavailability in the Environment; 7.1.2 Compound Half-life and Clearance; 7.2 Degradation of PPCPs in the Environment; 7.2.1 Degradation of Antibiotics in the Environment |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drugs |
| General subdivision | Toxicology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hygiene products |
| General subdivision | Toxicology. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drugs |
| General subdivision | Environmental aspects. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Hygiene products |
| General subdivision | Environmental aspects. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Environmental toxicology. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | SCIENCE / Chemistry / Organic. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | TECHNOLOGY & ENGINEERING / Environmental / Pollution Control. |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drugs |
| General subdivision | Toxicology. |
| Source of heading or term | fast |
| Authority record control number or standard number | (OCoLC)fst00898958 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Environmental toxicology. |
| Source of heading or term | fast |
| Authority record control number or standard number | (OCoLC)fst00913536 |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | MEDICAL / Pharmacology |
| Source of heading or term | bisacsh |
| 655 #4 - INDEX TERM--GENRE/FORM | |
| Genre/form data or focus term | Electronic books. |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Relationship information | Print version: |
| Main entry heading | Jjemba, Patrick K., author. |
| Title | Pharma-ecology |
| Edition | Second edition. |
| Place, publisher, and date of publication | Hoboken, NJ : Wiley, [2018] |
| International Standard Book Number | 9781119312284 |
| Record control number | (DLC) 2018027837 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1002/9781119312321">https://doi.org/10.1002/9781119312321</a> |
| Public note | Wiley Online Library |
| 880 8# - ALTERNATE GRAPHIC REPRESENTATION | |
| Linkage | 505-00/(S |
| a | 7.2.1.1 Degradation of Quinolone Compounds7.2.1.2 Fate of β-Lactams and Cephalosporins; 7.2.1.3 Degradation of Tetracyclines; 7.2.1.4 Degradation of Macrolides; 7.2.1.5 Fate of Other Important Groups of Antibiotics; 7.2.2 Degradation of Analgesics and Anti-inflammatory Drugs; 7.2.3 Degradation of Estrogens and Other Reproductive Hormones; 7.2.4 Degradation of Other Important Pharmaceuticals; 7.2.5 Degradation of Surfactants; 7.3 Role of Physicochemical Factors in the Fate of PPCPs in the Environment; 7.3.1 Molecular Size as an Attribute to Absorption and Persistence |
| 994 ## - | |
| -- | 92 |
| -- | DG1 |
No items available.